Bio-Techne Corp (STU:TE1)
€ 62.8 -0.26 (-0.41%) Market Cap: 9.81 Bil Enterprise Value: 9.88 Bil PE Ratio: 103.77 PB Ratio: 5.37 GF Score: 86/100

Q1 2024 Bio-Techne Corp Earnings Call Transcript

Oct 31, 2023 / 01:00PM GMT
Release Date Price: €51 (-9.73%)
Operator

Good morning, and welcome to the Bio-Techne Earnings Conference Call for the First Quarter of Fiscal Year 2024. (Operator Instructions)

I would now like to turn the call over to David Clair, Bio-Techne's Vice President, Investor Relations.

David Clair
Bio-Techne Corporation - Senior Director of IR & Corporate Development

Good morning, and thank you for joining us. On the call with me this morning are Chuck Kummeth, Bio-Techne's Chief Executive Officer; Jim Hippel, Chief Financial Officer; and Kim Kelderman, Chief Operating Officer.

Before we begin, let me briefly cover our safe harbor statement. Some of the comments made during this conference call may be considered forward-looking statements, including beliefs and expectations about the company's future results. The company's 10-K for fiscal year 2023 identifies certain factors that could cause the company's actual results to differ materially from those projected in the forward-looking statements made during this call. The company does not undertake to update any forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot